Plasma LDH: A specific biomarker for lung affectation in COVID-19?

Plasma LDH: A specific biomarker for lung affectation in COVID-19?

Objectives: We aimed to determine whether the plasma profile of lactate dehydrogenase (LDH) isoenzymes is altered in patients with COVID-19, and whether this is attributable to a specific release of LDH-3, the main LDH isoenzyme expressed in lungs. Design: We collected fresh plasma aliquots from 17...

Full description

Bibliographic Details
Main Authors: Arenas, J. (Author), Blázquez, A. (Author), COVID-19 '12 Octubre' Hospital Clinical Biochemistry Study Group (Author), Coya, O.N (Author), Cueto-Felgueroso, C. (Author), de Miguel-Reyes, M. (Author), Delmiro, A. (Author), López-Jimenez, A. (Author), Lucia, A. (Author), Martín, M.A (Author), Pozo, A.F.-D (Author), Santos-Lozano, A. (Author), Serrano-Lorenzo, P. (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2021
Subjects:
adult
aged
alanine aminotransferase
albumin
Article
aspartate aminotransferase
blood sampling
C reactive protein
clinical article
cohort analysis
controlled study
coronavirus disease 2019
COVID-19
creatinine
densitometry
disease association
enzyme activity
enzyme analysis
enzyme release
female
ferritin
hematological parameters
human
human cell
lactate dehydrogenase
Lactate dehydrogenase
lactate dehydrogenase 1
lactate dehydrogenase 2
lactate dehydrogenase 3
lactate dehydrogenase 4
lactate dehydrogenase A
lactate dehydrogenase blood level
lactate dehydrogenase isoenzyme
LDH isoenzymes
lung disease
lymphocyte count
male
middle aged
protein electrophoresis
protein expression
SARS-CoV-2
unclassified drug
very elderly
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items